isoxazoles has been researched along with Peripheral Nerve Diseases in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (80.00) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Centner, CM; Chirehwa, M; Court, R; de Vries, N; Denti, P; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Wiesner, L | 1 |
Cheng, X; Dougherty, PM; Heijnen, CJ; Huo, X; Kavelaars, A; Li, Y; Mei, F; Singhmar, P | 1 |
Conradie, F; Evans, D; Louw, R; Mabaso, S; Mabiletsa, T; Sefoka, M; Van Rie, A | 1 |
Sachdev, N; Weimer, LH | 1 |
Carulli, MT; Davies, UM | 1 |
Bonnel, RA; Graham, DJ | 1 |
Bharadwaj, A; Haroon, N | 1 |
Holden, WL; Scarazzini, LJ | 1 |
Guay, DR | 1 |
Bégaud, B; Bentaberry, F; Dehais, J; Dumoulin, C; Haramburu, F; Lifermann, F; Longy-Boursier, M; Martin, K; Moore, N; Schaeverbeke, T | 1 |
Hartmann, JT; Kanz, L; Kopp, HG; Moerike, K | 1 |
Chaudhry, V; Umapathi, T | 1 |
Arlt, AC; Brandt, J; Gross, WL; Metzler, C | 1 |
Bentaberry, F; Dehais, J; Dumoulin, C; Haramburu, F; Martin, K; Miremont-Salamé, G; Schaeverbeke, T | 1 |
Kermode, AG; Kho, LK | 1 |
3 review(s) available for isoxazoles and Peripheral Nerve Diseases
Article | Year |
---|---|
Update on medication-induced peripheral neuropathy.
Topics: Acetamides; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumatic Agents; Clinical Trials as Topic; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Linezolid; Oxazolidinones; Peripheral Nervous System Diseases; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2009 |
Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.
Topics: Aged; Analgesics, Non-Narcotic; Animals; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fructose; Humans; Isoxazoles; Levetiracetam; Oxcarbazepine; Pain; Peripheral Nervous System Diseases; Piracetam; Topiramate; Zonisamide | 2003 |
Toxic neuropathy.
Topics: Animals; Boronic Acids; Bortezomib; Clinical Trials as Topic; Epothilones; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoxazoles; Leflunomide; Neuritis; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyrazines; Pyridoxine; Thalidomide | 2005 |
12 other study(ies) available for isoxazoles and Peripheral Nerve Diseases
Article | Year |
---|---|
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Depression; Female; HIV Infections; Humans; Incidence; Isoxazoles; Male; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |
Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
Topics: Animals; Antineoplastic Agents; Astrocytes; Disease Models, Animal; Female; Ganglia, Spinal; Guanine Nucleotide Exchange Factors; Hydrazones; Hyperalgesia; Isoxazoles; Male; Mice; Mice, Knockout; Nerve Fibers; Paclitaxel; Pain Threshold; Peripheral Nervous System Diseases; Spinal Cord | 2018 |
Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB.
Topics: Humans; Incidence; Isoniazid; Isoxazoles; Oxazolidinones; Peripheral Nervous System Diseases; Prevalence; Tuberculosis, Multidrug-Resistant | 2013 |
Peripheral neuropathy: an unwanted effect of leflunomide?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Sedimentation; Female; Humans; Isoxazoles; Leflunomide; Male; Peripheral Nervous System Diseases | 2002 |
Peripheral neuropathy in patients treated with leflunomide.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Chi-Square Distribution; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Peripheral Nervous System Diseases; Proportional Hazards Models; United States; United States Food and Drug Administration | 2004 |
Peripheral neuropathy in patients on leflunomide.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Peripheral Nervous System Diseases | 2004 |
Postmarketing surveillance for drug safety.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug-Related Side Effects and Adverse Reactions; Humans; Isoxazoles; Leflunomide; Peripheral Nervous System Diseases; Product Surveillance, Postmarketing; Safety; United States; United States Food and Drug Administration | 2004 |
Neuropathy associated with leflunomide: a case series.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Peripheral Nervous System Diseases | 2005 |
Leflunomide and peripheral neuropathy: a potential interaction between uracil/tegafur and leflunomide.
Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Comorbidity; Disease Progression; Drug Administration Schedule; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fluorouracil; Humans; Isoxazoles; Leflunomide; Male; Peripheral Nervous System Diseases; Polyneuropathies; Rectal Neoplasms; Tegafur; Time Factors; Uracil | 2005 |
Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.
Topics: Adult; Aged; Antirheumatic Agents; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Rheumatic Diseases | 2005 |
Peripheral neuropathy associated with leflunomide: is there a risk patient profile?
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Complications; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Neurologic Examination; Peripheral Nervous System Diseases; Rheumatoid Factor; Risk Assessment; Vasculitis | 2007 |
Leflunomide-induced peripheral neuropathy.
Topics: Adjuvants, Immunologic; Aged; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Peripheral Nervous System Diseases | 2007 |